Saltar ao contenido
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Todos os campos
Title
Autor
Subject
Número de Clasificación
ISBN/ISSN
Tag
Buscar
Avanzado
Cetuximab plus Irinotecan as t...
Citar
Text this
Enviar este rexistro por email
Imprimir
Exportar rexistro
Exportar a RefWorks
Exportar a EndNoteWeb
Exportar a EndNote
Permanent link
Cetuximab plus Irinotecan as third line chemotherapy for metastatic colorectal cancer
Detalles Bibliográficos
Main Authors:
Moe, M
,
Micallef, R
,
Pwint, T
,
Maughan, T
,
Mort, D
,
Wagstaff, J
Formato:
Journal article
Publicado:
2008
Existencias
Descripción
Títulos similares
Staff View
Títulos similares
Regorafenib versus Cetuximab plus Irinotecan in Third-line Metastatic Colorectal Cancer in Iran: A Model-based Cost-utility Analysis
por: Meysam Seyedifar, et al.
Publicado: (2024-10-01)
EGFR related mutational status and association to clinical outcome of third-line cetuximab-irinotecan in metastatic colorectal cancer
por: Frifeldt Sanne K, et al.
Publicado: (2011-03-01)
Panitumumab versus cetuximab in combination with irinotecan in refractory metastatic colorectal cancer
por: Maria Ignez Freitas Melro Braghiroli, et al.
Publicado: (2024-01-01)
Cetuximab therapy in first-line metastatic colorectal cancer and intermittent palliative chemotherapy: review of the COIN trial.
por: Adams, R, et al.
Publicado: (2008)
First‐line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component
por: Yu‐Wen Zhou, et al.
Publicado: (2021-05-01)